- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY 2.94 Å
- Oligo State
- homo-trimer
- Ligands
- 8 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 7 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA.2: 3 residues within 4Å:- Chain A: N.792, S.794, Q.795
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.3: 4 residues within 4Å:- Chain A: N.708, L.913, Q.917, Q.1062
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:L.913
NAG-NAG-BMA.4: 4 residues within 4Å:- Chain A: N.1089, T.1091, H.1092, F.1094
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.10: 3 residues within 4Å:- Chain B: N.792, S.794, Q.795
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.12: 4 residues within 4Å:- Chain C: N.1089, T.1091, H.1092, F.1094
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.14: 3 residues within 4Å:- Chain C: N.792, S.794, Q.795
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.15: 4 residues within 4Å:- Chain C: N.708, L.913, Q.917, Q.1062
2 PLIP interactions:2 interactions with chain C- Hydrophobic interactions: C:L.913, C:Q.917
- 17 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.16: 3 residues within 4Å:- Chain A: N.607, Q.635
- Chain B: I.825
Ligand excluded by PLIPNAG.17: 3 residues within 4Å:- Chain A: S.699, N.700
- Chain B: Y.787
Ligand excluded by PLIPNAG.18: 1 residues within 4Å:- Chain A: N.1065
Ligand excluded by PLIPNAG.19: 2 residues within 4Å:- Chain A: T.102, N.226
Ligand excluded by PLIPNAG.20: 2 residues within 4Å:- Chain A: E.273, N.274
Ligand excluded by PLIPNAG.21: 3 residues within 4Å:- Chain A: N.323, P.570, Q.571
Ligand excluded by PLIPNAG.22: 3 residues within 4Å:- Chain A: R.338, A.340, N.346
Ligand excluded by PLIPNAG.23: 3 residues within 4Å:- Chain A: Y.646, V.647, N.648
Ligand excluded by PLIPNAG.24: 2 residues within 4Å:- Chain A: H.331, N.335
Ligand excluded by PLIPNAG.25: 2 residues within 4Å:- Chain B: N.607, T.609
Ligand excluded by PLIPNAG.26: 2 residues within 4Å:- Chain B: N.708, Q.1062
Ligand excluded by PLIPNAG.27: 1 residues within 4Å:- Chain B: N.1065
Ligand excluded by PLIPNAG.28: 3 residues within 4Å:- Chain B: Y.25, N.27, Q.210
Ligand excluded by PLIPNAG.29: 2 residues within 4Å:- Chain C: N.607, T.609
Ligand excluded by PLIPNAG.30: 2 residues within 4Å:- Chain A: Y.787
- Chain C: N.700
Ligand excluded by PLIPNAG.31: 1 residues within 4Å:- Chain C: N.323
Ligand excluded by PLIPNAG.32: 1 residues within 4Å:- Chain C: N.274
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Feng, Z., Structure of SARS-CoV-2 KP.3.1.1 Spike Protein. To Be Published
- Release Date
- 2025-05-28
- Peptides
- Spike glycoprotein: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY 2.94 Å
- Oligo State
- homo-trimer
- Ligands
- 8 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 7 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 17 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Feng, Z., Structure of SARS-CoV-2 KP.3.1.1 Spike Protein. To Be Published
- Release Date
- 2025-05-28
- Peptides
- Spike glycoprotein: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C